CHRISTIE BALLANTYNE to Proteomics
This is a "connection" page, showing publications CHRISTIE BALLANTYNE has written about Proteomics.
Connection Strength
1.601
-
Correlations Within and Between Highly Multiplexed Proteomic Assays of Human Plasma. Clin Chem. 2025 Jun 03; 71(6):677-687.
Score: 0.174
-
Circulating Blood Plasma Profiling Reveals Proteomic Signature and a Causal Role for SVEP1 in Sudden Cardiac Death. Circ Genom Precis Med. 2024 Oct; 17(5):e004494.
Score: 0.165
-
Large-Scale Proteomics Identifies Novel Biomarkers and Circulating Risk Factors for Aortic Stenosis. J Am Coll Cardiol. 2024 02 06; 83(5):577-591.
Score: 0.158
-
Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life. Sci Transl Med. 2023 07 19; 15(705):eadf5681.
Score: 0.152
-
Comparison of Proteomic Measurements Across Platforms in the Atherosclerosis Risk in Communities (ARIC) Study. Clin Chem. 2023 01 04; 69(1):68-79.
Score: 0.147
-
Proteomics and Risk of Atrial Fibrillation in Older Adults (From the Atherosclerosis Risk in Communities [ARIC] Study). Am J Cardiol. 2021 12 15; 161:42-50.
Score: 0.137
-
Proteins Associated with Risk of Kidney Function Decline in the General Population. J Am Soc Nephrol. 2021 09; 32(9):2291-2302.
Score: 0.134
-
Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk. Nat Aging. 2021 05; 1(5):473-489.
Score: 0.131
-
Reproducibility and Variability of Protein Analytes Measured Using a Multiplexed Modified Aptamer Assay. J Appl Lab Med. 2019 07; 4(1):30-39.
Score: 0.112
-
Large scale plasma proteomics identifies novel proteins and protein networks associated with heart failure development. Nat Commun. 2024 Jan 15; 15(1):528.
Score: 0.039
-
Proteomic Predictors of Incident Diabetes: Results From the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 2023 04 01; 46(4):733-741.
Score: 0.037
-
Alterations in the Circulating Proteome Associated with Albuminuria. J Am Soc Nephrol. 2023 06 01; 34(6):1078-1089.
Score: 0.037
-
A proteomic approach for investigating the pleiotropic effects of statins in the atherosclerosis risk in communities (ARIC) study. J Proteomics. 2023 02 10; 272:104788.
Score: 0.037
-
Long-term changes in plasma proteomic profiles in premenopausal and postmenopausal Black and White women: the Atherosclerosis Risk in Communities study. Menopause. 2022 10 01; 29(10):1150-1160.
Score: 0.036
-
Growth Differentiation Factor 15 and the Subsequent Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study. Clin Chem. 2022 07 27; 68(8):1084-1093.
Score: 0.036
-
APOL1 Kidney Risk Variants and Proteomics. Clin J Am Soc Nephrol. 2022 05; 17(5):684-692.
Score: 0.035
-
A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk. Sci Transl Med. 2022 04 06; 14(639):eabj9625.
Score: 0.035